Focal Onset Seizures clinical trials

Explore recruiting focal onset seizures clinical trials.

Recruiting focal onset seizures studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Focal Onset Seizures trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

A Randomized, Double-blind, Placebo-Controlled, Multicenter Phase 3 Study to Evaluate the Safety, Tolerability, and Efficacy of XEN1101 as Adjunctive Therapy in Focal-Onset Seizures

Bulgaria, Italy, Spain, Croatia, Portugal, Czechia +8 more

Therapeutic confirmatory (Phase III) EU CTIS Study details

A Randomized Phase 2 Study of Adjunctive EQU-001 for Uncontrolled Focal Onset Seizures

Sweden, Italy, France, Spain, Netherlands, Czechia +2 more

Therapeutic exploratory (Phase II) EU CTIS Study details

A Randomized, Double-blind, Placebo-Controlled, Multicenter Phase 3 Study to Evaluate the Safety, Tolerability, and Efficacy of XEN1101 as Adjunctive Therapy in Focal-Onset Seizures

Spain, Poland, Bulgaria, Italy, Germany, Ireland +3 more

Therapeutic confirmatory (Phase III) EU CTIS Study details

RENAISSANCE 2: A Double-Blind, Randomized, Placebo-Controlled, Multicenter, Parallel-Group Study to Evaluate the Efficacy, Safety, and Tolerability of SPN-817 in Adults with Focal Onset Seizures

Poland, Hungary, Bulgaria

Therapeutic exploratory (Phase II) EU CTIS Study details

A Double-Blind, Randomized, Placebo and Active Controlled Study to Evaluate the Efficacy and Safety of Once Daily, Extended Release Levetiracetam as Add-on Therapy in Patients with Refractory Partial Onset Epilepsy.

Poland, Romania, Germany, Czechia, Bulgaria, Italy +3 more

Therapeutic confirmatory (Phase III) EU CTIS Study details

Open Label Extension Clinical Trial of Vormatrigine in Adult Patients with Epilepsy.

Germany, Spain, Poland, Italy

Therapeutic confirmatory (Phase III) EU CTIS Study details

Focal Onset Seizures trials by city

Focal Onset Seizures in Toronto Focal Onset Seizures in Vancouver Focal Onset Seizures in Montreal Focal Onset Seizures in Calgary Focal Onset Seizures in Edmonton Focal Onset Seizures in Ottawa Focal Onset Seizures in Winnipeg Focal Onset Seizures in Quebec City Focal Onset Seizures in Hamilton Focal Onset Seizures in Kitchener Focal Onset Seizures in London Focal Onset Seizures in Halifax Focal Onset Seizures in New York Focal Onset Seizures in Los Angeles Focal Onset Seizures in Chicago Focal Onset Seizures in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease